NEWS

Training in the Urolastic procedure provided for doctors from Croatia and Bosnia and Herzegovina

Thirty doctors from Croatia and Bosnia and Herzegovina attended the Urolastic workshop organized by our distributors Elva Pharma, on the 5th May2017 in Opatija, Croatia.
The training was performed by Dr. Mija Blaganje, urogynaecologist at the Ljubljana University Medical Centre in Slovenia and Dr. Pieter Minnee, urologist at The Lange Land hospital in The Netherlands.
The training program included lectures by our expert practitioners on how to apply Urolastic and the benefits of choosing this procedure for treating patients with stress urinary incontinence. In addition, participants were given practical demonstrations of the Urolastic procedure. We are happy to announce the workshop was a success and are looking forward to future workshops in Croatia.
More information about Urolastic workshops organized in Croatia can be found by contacting our distributors at: info@elvapharma.com

NEWS

Urolastic workshop in Opatija, Croatia

On the 5th May 2017, 15 doctors from Croatia and Bosnia & Herzegovina will attend a Urolastic training workshop organized by our distributors in Croatia, ELVA Pharma.
The workshop will take place at the Hotel Admiral in Opatija and doctors will be trained in performing the Urolastic procedure. We will post photos and further information following the event.
For more information regarding training and workshops in Croatia, please contact our distributor at info@elvapharma.com.

NEWS

Legacy Medical, our South African distributors, present at the RCOG World Congress 2017 in Cape Town

The RCOG World Congress 2017, now incorporating the ISUOG’s 13th International Symposium, was held at the Cape Town International Convention Centre, South Africa on the 20 – 22 March 2017.
With over 14,000 Fellows and Members worldwide, the Royal College of Obstetricians and Gynaecologists (RCOG) encourages the study and advancement of the science and practice of obstetrics and gynaecology.

Our distributor Legacy Medical attended the congress and showcased our product for treating stress urinary incontinence in women – Urolastic.
Delegates from more than 70 countries , 22 African , attended in what is described as the “Tavern of Seas” setting at the Southern tip of the Continent. It was a true Global event with attendees in the excess of 2000 with many local and world leading.

You can find more information regarding the availability of Urolastic in South Africa by contacting our distributors at info@legacymedical.co.za or on their website: www.legacymedical.co.za

NEWS

We would like to introduce you to our new distributor for Iran, Kimia Behboud Arman

Kimia Behboud Arman is a pharmaceutical company focused on supplying laboratory equipment, medical equipment and pharmaceutical products that match high international standards to universities, hospitals, clinics, doctor’s practices in Iran.

Kimia Behboud Arman seeks to help diagnose and treat disease in a timely fashion, and offer valuable services to customers to help improve healthcare in society.

Urogyn are happy to announce that we have entered into a partnership with Kimia Behboud Arman and are looking forward to have them promote our innovative products for treating stress urinary incontinence, a growing problem that affects millions of people worldwide.

You can learn more about the company by visiting their website: www.kimiabehboud.com

NEWS

Training for specialists in The Netherlands or abroad

The first workshop of the year took place at the beginning of January and was organised for international doctors interested in our procedure for treating female stress urinary incontinence.
Dr. Brigida Rocchi from the Ospedale “Treviglio-Caravaggio” in Italy and Prof. Zurab Rainauli, from the University Klinik Tbilisi Cancer Center, in Georgia attended this training session take took place at the LangeLand Hospital in Zoetermeer , The Netherlands.
The goal of our workshops is to offer doctors the opportunity to gain a detailed understanding of our product Urolastic.
The workshops provide a comprehensive description of the product, its performance on recent clinical trials and the opportunity to observe practical demonstrations of the procedure.
We believe the workshops to be of benefit to any doctor who may in future wish to perform Urolastic procedures.
If you are a specialist and wish to receive training in our procedures please contact us by sending an e-mail to info@urogynbv.com.

NEWS

Urogyn soon on the television channel N1

Last week N1 (local TV-station) visited Urogyn to shoot an interview about Urolastic for the new TV show ‘NIJMEEGSE KENNIS’. The program makers are looking for innovative developments and products with their origin in Nijmegen. The series of 7 or 8 innovative ideas show there are lots of interesting developments going on in Nijmegen.
One of the innovative products showcased in the series will be Urolastic, the minimally-invasive treatment for stress urinary incontinence in women. The series will be broadcast in March and April on N1. When the exact date and time of the broadcast are known, we will announce it here.

NEWS

Leader Biomedical and Urogyn collaborate to bring innovative new procedure Urolastic™ to India

Amsterdam, The Netherlands- Urogyn B.V. and Leader Biomedical are proud to announce that Urolastic™ – an innovative Urinary Stress incontinence product – has been introduced into the product registration process in India. This marks the first step towards bringing a novel therapeutic solution to patients and caregivers in India.

Many women suffer from Stress Urinary Incontinence (SUI), radically affecting their quality of life due to restraining problems. Their social life is negatively influenced by involuntary leakage during coughing, sneezing, laughing or exercise. Urogyn has developed a product that shares the properties of being injectable, but does not shrink or degrade, thus remaining effective in the longer term. The material will also show up on X-rays and ultrasound, and can be removed if required.

Urolastic™ is an extremely biocompatible rubbery compound that forms in place after injection. The product consists of a dual syringe that is connected to a static mixing tube with a needle. When the dual syringe is compressed, the two components meet and mix in the static mixing tube. The mixed compound is then passed through the needle. This permits small amounts of compound to be placed in the tissue around the urethra. The mixture forms as small flexible balls, which are over time encapsulated in scar tissue.

“Urogyn B.V. has developed a unique, innovative, cost effective, and above all, female friendly procedure for the treatment of urinary incontinence in women. Our product Urolastic™ provides a minimally-invasive treatment, which is performed under local anesthesia and delivers long-lasting improvements to the quality of life of the patient. Through our new partnership with Leader Biomedical we are able to bring this state of the art treatment for Urinary Stress incontinence to the Indian market.” says Martijn Ligtenberg, COO/CFO, Urogyn B.V.

“The collaboration with Urogyn allows us to further increase our downstream value chain and supports our vision to continuously improve global access to next generation healthcare to India. We see great promise for this product here and we are diligently evaluating opportunities to carry the product in the Leader Biomedical network globally. As part of this larger goal, the product is expected to be introduced in India in the lag end of FY 2017”, adds Basil Babychan, Business Director, Leader Biomedical Group.

About Urogyn: Urogyn was founded in 2009 with the ambition of developing new products in the field of urology and gynaecology, based upon a two-component polymer technology. The first products are now used in the treatment of Stress Urinary Incontinence (SUI) for both men and women. More products are expected to be commercially launched in the near future for birth control and treating faecal incontinence (www.urogynbv.com).

About Leader Biomedical: Leader Biomedical seeks to become a leader in the supply of biomaterials and surgical implants, improving global markets’ access to next generation technologies, and medical devices (www.leaderbiomedical.com).

NEWS

Urogyn present at the first scientific meeting of The Parisian Institute of the Pelvic floor & Incontinence

The Parisian Institute of Pelvic floor & Incontinence, organizes its first scientific meeting on Saturday 7 January 2017 at the Royal Pavilion in Paris.

The “Parisian Institute of Pelvic floor & Incontinence” is a health association whose main objective is the multidisciplinary management of pelvic floor disorders, health and quality of life of women.

The scientific program covers the treatment of female urinary incontinence, from diagnosis to treatment.

Innovative new techniques and projects will be presented by the speakers and doctors can visit the Urogyn booth where they will be able to see our incontinence products and sign up for training sessions.

NEWS

Welcome to our new website

Welcome to our new company website. We hope that the new format will allow you to find the information you need more quickly and easily.

We are continuing to update our website with useful information and news regarding our company and products, so please do check back with us for updates.

Please feel free to contact us if you need more information at info@urogynbv.com.

NEWS

Elva Pharma, our new partner in Croatia!

We are pleased to announce that we have entered into an agreement with Elva Pharma which makes them our exclusive distributor in Croatia.
Elva pharma offers the broad knowledge base of highly experienced, “big pharma” trained professionals, which covers all aspects of the pharmaceutical value chain.
We look forward to working with them and supporting them in bringing our innovative products to the Croatian market.
For further information, please visit their website: www.elvapharma.com

NEWS

Our products soon available in Colombia

To support our growing list of worldwide distributors, we have appointed the company Gilmedica SA to distribute our products in Colombia.

Gilmedica  is a Colombian company, whose headquarters is located in Acopi Yumbo and has commercial and technical offices in major cities throughout the country, dedicated to importing, marketing and distribution of medical devices and equipment, with more than 36 years of experience in the sector.

To find out more please visit their website www.gilmedica.com

NEWS

New distributor announcement in Slovakia and Czech Republic

Urogyn is pleased to announce that we have signed an agreement with Archie Samuel s.r.o. to have appointed them as our exclusive distributor for Czech Republic and Slovakia. Established in 1995, the company is specialized in services for the health care industry with a focus on distribution of urology, uro-gynaecology and onco-urology products.

We welcome Archie Samuel s.r.o. to our international distributor network and look forward to a fruitful collaboration.